The Indian regulatory body has approved emergency use of both Serum Institute developed Covishield and Bharat Biotech's Covaxin to combat the coronavirus
During his three-city visit Prime Minister Narendra Modi will review the development and manufacturing of three vaccine candidates by Zydus, Bharat Biotech and Serum Institute of India respectively.
As India begins human trials of coronavirus, the liberal media needs to learn its lessons from its own conduct on how to be respectful, should we not succeed at first go.